BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6488174)

  • 21. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemosensitivity test for gynecologic malignancies by in vitro colony assay].
    Kano T; Nishida Y; Sakakibara K; Ohta M; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2827-36. PubMed ID: 4086909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
    Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
    Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic analysis of in vitro and in vivo brain tumor models.
    Schuster JM; Friedman HS; Bigner DD
    Neurol Clin; 1991 May; 9(2):375-82. PubMed ID: 1944106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma.
    Siegel MM; Chung HS; Rucker N; Siegel SE; Seeger RC; Isaacs H; Benedict WF
    Cancer Treat Rep; 1980; 64(8-9):975-9. PubMed ID: 7448832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
    Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    Drees M; Dengler WA; Roth T; Labonte H; Mayo J; Malspeis L; Grever M; Sausville EA; Fiebig HH
    Clin Cancer Res; 1997 Feb; 3(2):273-9. PubMed ID: 9815683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells.
    Lin YH; Chiu JH; Tseng WS; Wong TT; Chiou SH; Yen SH
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):525-32. PubMed ID: 16172905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
    von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
    BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation.
    Helson L; Rozsa P; Hajdu E; Helson JL
    Cancer Treat Rep; 1980; 64(12):1287-94. PubMed ID: 7471118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B; Sibamoto J; Abe M
    Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
    Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro chemosensitivity assay for human osteosarcoma using tumor xenografts.
    Fujisaki T; Wada T; Takahashi M; Yamawaki S; Ishii S
    Clin Orthop Relat Res; 1995 Apr; (313):279-85. PubMed ID: 7641491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
    Ali-Osman F; Giblin J; Dougherty D; Rosenblum ML
    Cancer Res; 1987 Jul; 47(14):3718-24. PubMed ID: 2954633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
    Aamdal S; Fodstad O; Pihl A
    Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro chemosensitivity test of human solid cancer: 3H-thymidine uptake inhibition test].
    Hanatani Y; Kubota T; Ishibiki K; Abe O
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1123-9. PubMed ID: 6471418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hollow fiber assay: continued characterization with novel approaches.
    Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
    Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.